Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

Front Pharmacol. 2023 Jan 11:13:1123542. doi: 10.3389/fphar.2022.1123542. eCollection 2022.

Authors

Geeta S Bhagwat¹, Rajani B Athawale², Rajeev P Gude³, Shadab Md⁴, Nabil A Alhakamy⁴, Usama A Fahmy⁴, Prashant Kesharwani⁵

Affiliations

¹ H. K. College of Pharmacy, Mumbai, India.
² Prin. K. M. Kundanani College of Pharmacy, Mumbai, India.
³ Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
⁴ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
⁵ Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.614290.].

Keywords: breast cancer; cancer; solid lipid nanoparticles; tamoxifen; targeted drug delivery.

Copyright © 2023 Bhagwat, Athawale, Gude, Md, Alhakamy, Fahmy and Kesharwani.

Publication types

Published Erratum